Multifactorial treatment of hypertensive men at high cardiovascular risk and low-density lipoprotein cholesterol affinity to human arterial proteoglycans

被引:9
作者
Fagerberg, B
Wiklund, O
Agewall, S
Camejo, G
Wikstrand, RJ
机构
[1] ASTRA HASSLE AB, PRECLIN RES LABS, BIOCHEM, MOLNDAL, SWEDEN
[2] GOTHENBURG UNIV, SAHLGRENS UNIV HOSP, WALLENBERG LAB CARDIOVASC RES, S-41345 GOTHENBURG, SWEDEN
关键词
atherosclerosis; diet; hyperlipidaemia; hypertension; intervention; proteoglycan;
D O I
10.1046/j.1365-2362.1996.2030543.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The purpose of this work was to examine in an open, randomized parallel-group study whether an intervention programme directed towards hypercholesterolaemia, smoking and diabetes mellitus in treated hypertensive men was associated with less complex formation between low-density lipoprotein (LDL) and human arterial proteoglycans than was the case with usual care. The intervention consisted mainly of non-pharmacological treatment, but drug therapy could be instituted to achieve the treatment goals in the intervention group. The intervention programme was associated with a significant reduction in body mass index, and 46% of the patients were on lipid-lowering medication at the follow-up examination. The net differences were (intervention - usual care): change in serum LDL-cholesterol, -0.48 mmol L(-1) (95% confidence interval -0.84 to -0.11 mmol L(-1)), precipitated LDL-cholesterol, -5.5 mu g (95% CI -9.0 to -1.1 mu g). The latter remained after adjustment for the difference in serum LDL-cholesterol between the groups. Our conclusion is that the multifactorial risk factor treatment programme was associated,with a reduced tendency of LDL to form complexes with human arterial proteoglycans.
引用
收藏
页码:960 / 965
页数:6
相关论文
共 23 条
[21]   Insoluble complex formation between LDL and arterial proteoglycans in relation to serum lipid levels and effects of lipid lowering drugs [J].
Wiklund, O ;
Bondjers, G ;
Wright, I ;
Camejo, G .
ATHEROSCLEROSIS, 1996, 119 (01) :57-67
[22]   THE MULTIFACTOR PRIMARY PREVENTION TRIAL IN GOTEBORG, SWEDEN [J].
WILHELMSEN, L ;
BERGLUND, G ;
ELMFELDT, D ;
TIBBLIN, G ;
WEDEL, H ;
PENNERT, K ;
VEDIN, A ;
WILHELMSSON, C ;
WERKO, L .
EUROPEAN HEART JOURNAL, 1986, 7 (04) :279-288
[23]   THE RESPONSE-TO-RETENTION HYPOTHESIS OF EARLY ATHEROGENESIS [J].
WILLIAMS, KJ ;
TABAS, I .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (05) :551-561